
CRISPR knockout cell lines are engineered through targeted genome editing to eliminate gene function, supporting studies of cellular biology, disease mechanisms, and drug discovery.
MFE-280 is a human endometrial carcinoma cell line established from a recurrent, poorly differentiated endometrial tumor from an elderly patient. The cells were derived from tumor tissue and exhibit a complex heterogeneous karyotype. MFE-280 cells express cytokeratins, vimentin, and placental protein 14 (PP14), and have been reported to form tumors in immunodeficient mice. This cell line is used as a model for studying endometrial cancer biology and tumor-related mechanisms.
Before delivery, each clone is authenticated by STR, tested for sterility and mycoplasma, and genotype‑verified by two‑round PCR‑sequencing. Comprehensive QC data accompany every shipment to support reproducible research.

Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations
These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.
Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.

Knockout Region: E1
Reference Transcript: VHL-201
Validation Method: PCR amplification+Sanger sequencing
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use






Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours
* Name
* Institution
* Products & Services of Interest
If email is not available, how else can we reach you?
How did you hear about us?